'Fingerprints' of childhood cancer treatment provide clues that may help mitigate second cancers

Scientists at St. Jude in Memphis identified DNA 'fingerprints' from childhood cancer treatments that raise second cancer risk decades later. The discovery could improve early detection and reduce therapy toxicity for survivors.